Aadi Bioscience Inc.

NASDAQ: AADI · Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM

Aadi Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
21.6M 27.77M 25.98M 25.07M 23.82M 23.84M 24.35M 23.25M 21.54M 18.78M 15.22M 10.99M 6.74M 3.31M 1.12M 14.12M 14.35M 14.44M
Cost of Revenue
2.35M 3.13M 3.02M 3.16M 3.05M 2.93M 2.81M 2.1M 2M 1.69M 1.33M 1.22M 767.55K 438.22K 276K 14.17M 16.42M 21.06M
Gross Profit
19.24M 24.64M 22.96M 21.91M 20.76M 20.91M 21.55M 21.15M 19.54M 17.09M 13.88M 9.77M 5.98M 2.87M 844K -46K -2.07M -6.62M
Operating Income
-102.33M -63.16M -67.46M -66.22M -70.66M -74.62M -71.93M -69.69M -66.88M -65.69M -62.68M -63.16M -135.43M -121.84M -112.39M -88.04M -3.39M -3.71M
Interest Income
4.35M 3.43M 3.92M 4.75M 5.45M 6.02M 6.4M 6.51M 5.52M 4.04M 2.4M 805K 185K 28K 13K 1K 2K 21.12K
Pretax Income
-10.42M 27.61M -63.69M -61.69M -65.44M -68.83M -65.77M -63.42M -61.59M -61.88M -60.51M -62.58M -135.19M -121.34M -111.93M -100.66M -18.52M -19.4M
Net Income
-10.42M 27.61M -63.69M -61.69M -65.44M -68.83M -64.22M -61.86M -58.88M -59.18M -59.4M -61.48M -135.25M -121.39M -111.93M -100.66M -18.52M -19.64M
Selling & General & Admin
36.99M 38.94M 36.75M 36.04M 40.08M 43.96M 44.55M 45.31M 44M 42.23M 40.17M 38.79M 36.27M 30.32M 23.31M 15.99M 10.47M 6.94M
Research & Development
81.94M 46.23M 51.03M 49.45M 51.34M 51.57M 48.93M 45.53M 42.41M 36.82M 32.66M 30.52M 27.5M 22.82M 19.67M 17.77M 14.41M 16.01M
Other Expenses
2.64M 2.64M 2.64M 2.64M n/a n/a n/a n/a n/a n/a n/a n/a 380K 2.75M 1.59M 1.67M 1.29M -1.09M
Operating Expenses
121.57M 87.81M 90.42M 88.13M 91.42M 95.53M 93.48M 90.84M 86.42M 79.06M 72.84M 69.31M 63.77M 50.81M 39.24M 27.93M 20.63M 16.39M
Interest Expense
-270K -212K -154K 211K 231K 231K 231K 231K 231K 231K 231K 231K 330K 499K 665K 838K 910K 683K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a 1.96M 1.96M 1.96M 1.96M n/a n/a n/a 1.57M 3.56M 4.93M 4.93M
Cost & Expenses
69.18M 90.94M 93.44M 91.29M 94.48M 98.46M 96.29M 92.94M 88.42M 80.74M 74.17M 70.42M 64.29M 50.99M 39.24M 27.93M 20.63M 21.04M
Income Tax Expense
n/a n/a n/a n/a -44K -29K -1.57M -1.58M -2.69M -2.7M -1.11M -1.05M 263K 256K 135.85K 79.85K -73.15K -55.03K
Shares Outstanding (Basic)
69.08M 39.64M 27.09M 24.74M 27.01M 26.98M 26.97M 26.95M 26.88M 26.86M 26.84M 21.27M 20.97M 20.91M 20.89M 9.51M 9.51M 3.15M
Shares Outstanding (Diluted)
69.08M 39.93M 27.09M 24.74M 27.01M 26.98M 26.97M 26.95M 26.88M 26.86M 26.84M 21.27M 20.97M 20.91M 20.89M 9.51M 9.51M 3.15M
EPS (Basic)
-0.06 0.16 -2.36 -2.29 -2.42 -2.55 -2.38 -2.3 -2.33 -2.53 -2.68 -2.93 -11.46 -11.05 -11.8 -12.53 -3.61 -3.84
EPS (Diluted)
-0.07 0.15 -2.36 -2.29 -2.42 -2.55 -2.38 -2.3 -2.33 -2.53 -2.68 -2.93 -11.46 -11.05 -11.8 -12.53 -3.61 -3.84
EBITDA
-13.04M 27.23M -64.02M -61.28M -65.02M -68.42M -65.36M -63.02M -61.11M -61.32M -59.85M -61.86M -134.36M -120.67M -112.62M -88.39M -4.25M -4.94M
EBIT
40.95M 26.43M -64.82M -61.48M -65.21M -68.6M -65.53M -63.19M -61.36M -61.65M -60.28M -62.35M -134.87M -121.07M -111.71M -87.53M -3.26M -3.94M
Depreciation & Amortization
151K 200K 193K 190K 187K 181K 169K 171K 252K 327K 429K 493K 505.55K 399.22K 276K 168K 32.97K 23.54K